Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel in children and adolescents with bipolar I disorder or schizophrenia
NCT00227305Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2004
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of quetiapine (extended-release tablet, brand name: Bipresso) in schizophrenia, bipolar I disorder, sponsored by AstraZeneca. Started Aug 2004; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
schizophreniabipolar I disorder
Beyond the preview
Go deeper on NCT00227305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227305.